Indian Government Reacts To Cough Syrups Reportedly Linked To Death Of 66 Children In The Gambia

- Advertisement -

Following the World Health Organization (WHO) medical product alert regarding four cough syrups manufactured in India which are reportedly linked to the death of 66 children in Gambia, the Indian Government has reacted to the issues in a press statement.

The statement explains the action of the Indian Government after the alert by WHO.

- Advertisement -

“A detailed investigation was launched to ascertain the facts/details in the matter in collaboration with State Drugs Controller, Haryana.

From the preliminary enquiry of CDSCO, it has been made out that M/s Maiden Pharmaceutical Limited, Sonepat, Haryana is a manufacturer licensed by the State Drug Controller for the products Promethazine Oral Solution BP, Kofexnalin Baby Cough Syrup, MaKoff Baby Cough Syrup and MaGrip n Cold Syrup under reference and holds manufacturing permission for these products for export only. The company has manufactured and exported these products only to Gambia.”

The Indian government statement says “it is a usual practice that the importing country tests these imported products on quality parameters and satisfies itself as to the quality of the products before the importing country decides to release such products for usage in the country.”

It disclosed that “as per the tentative results received by WHO, out of the 23 samples of the products under reference which were tested, 04 samples have been found to contain Diethylene Glycol/ Ethylene Glycol. It has also been informed by WHO that the certificate of analysis will be made available to WHO in near future and WHO will share it with the Indian Regulator which is yet to be done. The exact one to one causal relation of death has not yet been provided by WHO to CDSCO.”

- Advertisement -

The national regulatory authority, CDSCO has requested WHO to share at the earliest with CDSCO the report on establishment of causal relation to death with the medical products in question etc.

The statement further confirms that State Drug Controller had given licenses to the said Company only for export of these four drugs namely Promethazine Oral Solution BP, Kofexnalin Baby Cough Syrup, MaKoff Baby Cough Syrup and MaGrip n Cold Syrup.

“Further all these 04 drugs manufactured only for exports by M/s. Maiden Pharmaceuticals Limited are not licensed for manufacture and sale in India. In effect, none of these four drugs of M/s. Maiden Pharmaceuticals is sold domestically in India.

The samples (controlled samples of the same batch manufactured by M/s. Maiden Pharmaceuticals Limited for all the four drugs in question) have been taken and sent for testing to Regional Drug Testing Lab, Chandigarh by CDSCO, the results of which will guide further course of action as well as bring clarity on the inputs received/ to be received from WHO,” the press statement explains.

Popular Posts